Browse the full insider trade history of enGene Therapeutics Inc., a publicly traded company based in Canada. Shares are listed on CA CA, under the supervision of SEDI. The latest transaction was reported on 19 June 2026 (50 - Grant of options). Among the most active insiders: Grossman, William. All data is free.
15
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
19Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.